Bin Xu1, Ronald Ghossein1, Alan Ho2, Kartik Viswanathan3, Anjanie Khimraj1, Maelle Saliba1, Jennifer R Cracchiolo4, Nora Katabi1. 1. Department of Pathology, Memorial Sloan-Kettering Cancer Center, New York, New York, USA. 2. Department of Medical Oncology, Memorial Sloan-Kettering Cancer Center, New York, New York, USA. 3. Department of Pathology, Massachusetts General Hospital, Boston, Massachusetts, USA. 4. Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, New York, USA.
Abstract
AIMS: In the era of precision medicine, accurate pathologic diagnoses are crucial for appropriate management. METHODS: We herein described the histologic features and clinical impacts of 66 salivary gland epithelial neoplasms in which the diagnosis was altered after expert review. RESULTS: The most common revised diagnosis was that of salivary duct carcinoma (SDC, n = 12), adenoid cystic carcinoma (n = 12), and myoepithelial carcinoma (n = 10). The most common initial diagnosis was mucoepidermoid carcinoma (n = 19) with SDC being the most common revised diagnosis (7/19). Thirteen salivary gland carcinomas were initially diagnosed as benign entities, whereas five benign tumors were initially interpreted as carcinoma. The change in diagnosis was considered to be clinically significant in 65 (97%) cases. CONCLUSIONS: Given their rarity, salivary gland neoplasms are prone to diagnostic inaccuracy and discrepancy. A constellation of histologic features and ancillary studies are useful in reaching the correct diagnosis, which can have significant clinical impacts.
AIMS: In the era of precision medicine, accurate pathologic diagnoses are crucial for appropriate management. METHODS: We herein described the histologic features and clinical impacts of 66 salivary gland epithelial neoplasms in which the diagnosis was altered after expert review. RESULTS: The most common revised diagnosis was that of salivary duct carcinoma (SDC, n = 12), adenoid cystic carcinoma (n = 12), and myoepithelial carcinoma (n = 10). The most common initial diagnosis was mucoepidermoid carcinoma (n = 19) with SDC being the most common revised diagnosis (7/19). Thirteen salivary gland carcinomas were initially diagnosed as benign entities, whereas five benign tumors were initially interpreted as carcinoma. The change in diagnosis was considered to be clinically significant in 65 (97%) cases. CONCLUSIONS: Given their rarity, salivary gland neoplasms are prone to diagnostic inaccuracy and discrepancy. A constellation of histologic features and ancillary studies are useful in reaching the correct diagnosis, which can have significant clinical impacts.
Authors: Stijn van Weert; Isaäc van der Waal; Birgit I Witte; C René Leemans; Elisabeth Bloemena Journal: Oral Oncol Date: 2014-10-28 Impact factor: 5.337
Authors: Meredith L Johnston; Shao Hui Huang; John N Waldron; Eshetu G Atenafu; Kelvin Chan; Bernard J Cummings; Ralph W Gilbert; David Goldstein; Patrick J Gullane; Jonathan C Irish; Bayardo Perez-Ordonez; Ilan Weinreb; Andrew Bayley; John Cho; Laura A Dawson; Andrew Hope; Jolie Ringash; Ian J Witterick; Brian O'Sullivan; John Kim Journal: Head Neck Date: 2015-07-15 Impact factor: 3.147
Authors: Cristina R Antonescu; Lei Zhang; Sung Yun Shao; Juan-Miguel Mosquera; Ilan Weinreb; Nora Katabi; Christopher D M Fletcher Journal: Genes Chromosomes Cancer Date: 2013-04-30 Impact factor: 5.006
Authors: Raja R Seethala; Jennifer L Hunt; Zubair W Baloch; Virginia A Livolsi; E Leon Barnes Journal: Am J Surg Pathol Date: 2007-11 Impact factor: 6.394